managed care companies Archives

TAG:

managed care companies

2019’s Top 10 Lab Stories Reveal Major Laboratory Industry Trends

This is an excerpt of a 3,163-word article in the Dec. 16, 2019 issue of THE DARK REPORT (TDR). The full article is available to members of The Dark Intelligence Group. CEO SUMMARY: There was plenty of bad news in 2019 for clinical labs and pathology groups. Yet lurking inside this new…

Ambry Genetics $800M Sale to Konica Minolta Is a Big Deal for Lab Industry

By Mary Van Doren | From the Volume XXIV No. 10 – July 17, 2017 Issue

This is an excerpt from a 2,026-word article in the July 17, 2017 issue of THE DARK REPORT. The complete article is available for a limited time to all readers, and available at all times to paid members of the Dark Intelligence Group. …

Konica Minolta to Pay Up to $1 Billion for Ambry

By Joseph Burns | From the Volume XXIV No. 10 – July 17, 2017 Issue

CEO SUMMARY: It’s the second time in six years that a Japanese corporation paid a high price for a genetic testing company in the United States. Konica Minolta will purchase Ambry Genetics for $800 million at closing and $200 million upon hitting certain financial metrics. In 2011, Miraca H…

Reference Pricing’s New Lab Winners and Losers

By Robert Michel | From the Volume XXIII No. 12 – September 6, 2016 Issue

CEO SUMMARY: Expanded use of reference pricing by employers in coming years could trigger a cycle of cuts to lab test prices that would put the most pressure on the lab companies with the highest prices. Many hospital labs are viewed as having high prices. But because they run outreach sp…

Payers Asking for Repayment When Labs Waive Fees

By Joseph Burns | From the Volume XXIII No. 7 – May 23, 2016 Issue

CEO SUMMARY: Health insurers appear to have stepped up their efforts to warn clinical laboratories not to waive patients’ fees in return for specimen referrals. Consultants also say that payers are increasing enforcement efforts. There are cases where, when insurers discover labs have n…

Test Utilization Targeted by UnitedHealth, LabCorp

By Joseph Burns | From the Volume XXI No. 10 – July 21, 2014 Issue

CEO SUMMARY: Many independent laboratories serving patients in Florida are unhappy about the decision by UnitedHealth (UNH) to initiate a pilot program that calls for LabCorp’s BeaconLBS subsidiary to handle prior authorization for certain lab tests. UNH’s laboratory benefit managemen…

Maine’s Spectrum Medical Group Offers Multiple Specialties

By Joseph Burns | From the Volume XXI No. 4 – March 17, 2014 Issue

CEO SUMMARY: Pathologists looking for a viable future in a healthcare system marked by integration of clinical care and value-based reimbursement will be interested to learn about Spectrum Medical Group based in Portland, Maine. This 180-member multispecialist group includes 22 pathologis…

Federal Judge Lets Trial Proceed in Case against Quest

By Joseph Burns | From the Volume XXI No. 3 – February 24, 2014 Issue

CEO SUMMARY: Four California labs have charged that Quest Diagnostics engaged in predatory pricing in a case filed originally in November 2012. After the lawsuit was amended last summer and fall, U.S. District Judge William H. Orrick III heard various motions in the case. On February 6 he…

Hospitals Recognize Need for Uniform Lab Test Data

By Joseph Burns | From the Volume XX No. 12 – September 9, 2013 Issue

CEO SUMMARY: Hospitals may soon insist that payers allow their in-house labs to provide outpatient testing regardless of exclusive managed care contracts with national lab companies. The migration to accountable care organizations (ACOs) and medical homes makes it essential that physician…

Anticipating 2013 Trends in Clinical Lab and Pathology

By Robert Michel | From the Volume XX No. 1 – January 22, 2013 Issue

CEO SUMMARY: Biggest news for 2013 will the impact of significant price cuts for both clinical lab and anatomic pathology testing services. But the bad news doesn’t stop there. Employers and private payers will be more aggressive in taking steps to reduce what they spend on lab testing….

Volume XXXI, No. 5 – April 8, 2024

The fragmentation of consumer markets is reflected in clinical lab services, and The Dark Report examines this trend and how it will impact labs in the coming years. Also, The Dark Report notes that the FDA has issued a controversial memo to reclassify many high-risk IVD assays.

See the full table of contents

How Much Laboratory Business Intelligence Have You Missed?

Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!

Need A Group Membership? Company Discounts are Available!

Sign up for TDR Insider

Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.

Topics

Visit The Dark Library

TAG:

managed care companies

CURRENT ISSUE

How Much Laboratory Business Intelligence Have You Missed?

Sign up for TDR Insider

Topics